Effect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men.
Soy consumption has been associated with a reduced risk of prostate cancer. The mechanism for this association may involve the effect of soy on the endocrine system. We conducted a randomized dietary intervention study to determine the effects of soy consumption on serum levels of steroid hormones in men. Thirty-five men were randomly assigned to either a soymilk-supplemented group or a control group. The men in the soy-supplemented group were asked to consume 400 ml of soymilk daily for 8 weeks. The men in the control group maintained their usual diet. Blood samples were obtained just before the initiation of the dietary period and thereafter every two weeks for 12 weeks. Changes in hormone concentrations were analyzed and compared between the two groups using the mixed linear regression model against weeks from the start of the dietary period. The mean (SD) soymilk intake estimated from dietary records during the dietary study period was 342.9 (SD, 74.2) ml in the soymilk-supplemented group. There was a significant difference between the two groups in terms of changes in serum estrone concentrations, which tended to decrease in the soy-supplemented group and increase in the control group over time. None of the other hormones measured (estradiol, total and free-testosterone, or sex hormone-binding globulin) showed any statistical difference between the two groups in terms of patterns of change. The results of the study indicate that soymilk consumption may modify circulating estrone concentrations in men.
Nagata
C
C
Department of Public Health, Gifu University School of Medicine, Japan.
Takatsuka
N
N
Shimizu
H
H
Hayashi
H
H
Akamatsu
T
T
Murase
K
K
D000328:Adult; D000728:Androgens / Q000097:blood*; D004032:Diet; D004967:Estrogens / Q000097:blood*; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D011336:Probability; D011471:Prostatic Neoplasms / Q000097:blood* / Q000178:diet therapy* / Q000453:epidemiology; D012016:Reference Values; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013025:Glycine max / Q000627:therapeutic use*
D000728:Androgens; D004967:Estrogens